Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

por Callaghan, R., Higgins, C. F.
Publicado 1995

The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models

por Martin, C, Walker, J, Rothnie, A, Callaghan, R
Publicado 2003

A comparison of membrane properties and composition between cell lines selected and transfected for multi-drug resistance.

por Callaghan, R., van Gorkom, L. C., Epand, R. M.
Publicado 1992

A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs

por Mellor, H R, Ferguson, D J P, Callaghan, R
Publicado 2005

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

por Taylor, J C, Ferry, D R, Higgins, C F, Callaghan, R
Publicado 1999

Antibody effector functions are required for broad and potent protection of neonates from herpes simplex virus infection

por Slein, Matthew D., Backes, Iara M., Garland, Callaghan R., Kelkar, Natasha S., Leib, David A., Ackerman, Margaret E.
Publicado 2023

Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model

por Modok, S, Scott, R, Alderden, R A, Hall, M D, Mellor, H R, Bohic, S, Roose, T, Hambley, T W, Callaghan, R
Publicado 2007

Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.

por Dale, I. L., Tuffley, W., Callaghan, R., Holmes, J. A., Martin, K., Luscombe, M., Mistry, P., Ryder, H., Stewart, A. J., Charlton, P., Twentyman, P. R., Bevan, P.
Publicado 1998

Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity

por Backes, Iara M., Byrd, Brook K., Slein, Matthew D., Patel, Chaya D., Taylor, Sean A., Garland, Callaghan R., MacDonald, Scott W., Balazs, Alejandro B., Davis, Scott C., Ackerman, Margaret E., Leib, David A.
Publicado 2022